Verification opinion on the reply to the regulatory inquiry letter on the disclosure of information in the 2023 annual report of sansure biotech inc. by western securities limited.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.